Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.29%) to 7684.30, DAX +0.02% to 17423.23, CAC40 (0.46%) to 7929.82, STOXX 600 (0.37%) to 495.43

Feb 26 ,2024

  • Synopsis:

    • European equity markets closed mostly lower with the exception of Germany. Follows broad gains last week, which saw STOXX 600 hit new all-time high. Basic Resources, Utilities and Real Estate the worst performing sectors, while Technology, Financial Services and Industrial Goods&Services outperformed.

    • Quiet macro calendar, leaving attention on speeches from BoE deputy chief Breeden and BoE economist Pill. ECB President Lagarde will also participate in plenary debate on ECB annual report during the European afternoon. Recent central bank speak has seen Fed officials continuing to highlight need for more evidence on inflation, driving another round of hawkish pivot repricing. Markets now pricing in three rate cuts in 2024, in-line with Fed's median outlook from December SEP. Similarly, markets pricing in ECB rate cuts of less than 100 bps 2024 and BoE rate cut expectations have also eased amid ongoing reluctance to signal near-term cut in rates.

    • CBI quarterly data showed pace of contraction in retail sales slowed; BCC survey showed most Britain exporters and manufacturers have felt impact from Red Sea supply chain disruptions; economists warn chancellor Hunt against spending cuts to finance pre-election tax giveaways. In other developments, Ukraine floats possibility of inviting Russia to peace summit while US and UK carry out fresh strikes on Houthi targets in Yemen.

    • Light earnings news flow with PostNL (PNL.NA) shares closed down (4.7%) after FY24 EBIT guidance was much weaker than expected. CIE Automotive (CIE.SM), Bank of Ireland Group (BIRG.ID), Bunzl (BNZL.LN), Retail Estates (RET.BB) and Liechtensteinische Landesbank (LLBN.SW) were among few other names updating investors before the open. In other notable updates, Sanofi (SAN.FP) reported positive results from the Phase 2 study RILECSU over the weekend. Roche (ROG.SW) reported positive data from Stage 1 of the NIH-sponsored Phase III OUtMATCH study evaluating Xolair (omalizumab) late on 25-Feb. Bayer (BAYN.GR) receives U.S. FDA Breakthrough Therapy Designation for BAY 2927088 for non-small cell lung cancer harboring HER2 activating mutations.

    • In M&A news, after announcing the deal last week, Saint-Gobain (SGO.FP) signed the definitive agreement to acquire CSR Limited (CSR.AU), with the closing expected in H2. In the Nordics, Kinnevik (KINV.B.SS) sold its entire shareholding in Tele2 (TEL2.B.SS) to an investment vehicle jointly controlled by iliad and NJJ for SEK 13B whilst - in the UK - Bunzl (BNZL.LN) acquired Nisbets in the UK and Pamark in Finland.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Technology +0.44%, Financial Svcs +0.32%, Ind Goods & Svcs (0.10%), Retail (0.18%), Media (0.23%), Insurance (0.27%), Construct & Mtls (0.30%)

      • Underperformers:

        • Basic Resources (2.02%), Utilities (1.29%), Real Estate (1.04%), Food, Beverage and Tobacco (0.82%), Personal Care Drug and Grocery Stores (0.64%), Consumer Products and Services (0.57%), Autos & Parts (0.47%), Energy(0.46%), Travel & Leisure (0.44%), Health Care (0.41%), Banks (0.41%), Telecom (0.40%)

    • Macro:

      • EU

        • EU members clash over efforts to centralize markets supervision - Bloomberg

        • Brussels' farmers protests: Stench of manure wafts through EU capital - Politico

        • EU elections: Renew Europe's Valérie Hayer to become Macron camp's top candidate - Euractiv

      • ECB

        • ECB's Makhlouf in no rush to cut as vigilance on wages needed - Bloomberg

        • Eurozone's painstaking crawl to price stability keeps ECB wary - Bloomberg

      • UK

        • Most UK exporters hit by Red Sea disruption, survey shows - Reuters

        • UK public services will buckle under planned spending cuts, economists warn - Guardian

        • UK seeks to spur business investment with coordinated ministerial push - Bloomberg

        • Britons at risk of lower pay than migrants under new visa salary rules - Telegraph

        • The peer, the pollster and the rumblings of a plan to oust Rishi Sunak - London Times

        • Who could replace Rishi Sunak? These are the agents of change - London Times

      • France

        • Farmers storm Paris agriculture fair as Macron promises more help - FT

      • Italy

        • Vote counting underway after key Sardinia poll - Ansa

    • Company news:

      • Notable Gainers

        • +35.7% ZEAL.DC (Zealand Pharma DKK648.50, +170.50) -- positive study results

        • +12.2% WIN.LN (Wincanton £5.04, +0.55) --

          • confirms a competing offer from GXO

          • directors continue to recommend unanimously to shareholders increased and final cash offer by CMA CGM announced

        • +7.1% TLT1V.FH (Teleste €2.70, +0.18) -- signs a Master Supply agreement with a prominent operator in North America

        • +6.8% BILI.A.SS (Bilia SEK130.20, +8.30) -- Dagens Industri out with buy recommendation

        • +6.5% COLR.BB (Colruyt Group €42.98, +2.61) -- transferred outperform at BNP Paribas Exane

        • +5.5% PCELL.SS (PowerCell Sweden SEK32.58, +1.69) -- initiated buy at Pareto

        • +5.4% KINV.B.SS (Kinnevik SEK106.95, +5.50) -- to sell its entire shareholding in Tele2 to an investment vehicle jointly controlled by iliad and NJJ for SEK 13B

          • +5.3% TEL2.B.SS (Tele2 SEK87.84, +4.42)

        • +4.4% TSTL.LN (Tristel £4.70, +0.20) --

          • H1 earnings

          • TANK ClO₂ sporicidal disinfectant system receives positive recommendation for UKCA and MDR certification

        • +3.8% HEX.NO (Hexagon Composites NOK21.10, +0.78) -- order

        • +3.2% TRMD.A.DC (TORM Plc DKK233.80, +7.20) -- initiated buy at Nordea

        • +2.8% RECSI.NO (REC Silicon NOK9.81, +0.27) -- announces inspection by Labor & Industries at Moses Lake

      • Notable Decliners

        • -10.5% NORTHM.DC (North Media DKK71.00, -8.30) -- prelim FY earnings

        • -10.3% BIRG.ID (Bank of Ireland Group €8.16, -0.94) -- Q4 earnings

        • -4.9% XBRANE.SS (Xbrane Biopharma SEK0.70, -0.04) -- Q4 earnings

        • -4.7% PNL.NA (PostNL €1.27, -0.06) -- Q4 earnings

        • -4.2% IPF.LN (International Personal Finance £1.14, -0.05) -- delays reporting of FY results due to communications from Polish Financial Supervision Authority

        • -3.2% SSH1V.FH (SSH Communications Security €1.35, -0.04) -- CEO steps down

        • -3.1% NK.FP (Imerys €30.14, -0.96) -- BNP Paribas Exane downgrade

        • -2.9% BNZL.LN (Bunzl £32.10, -0.96) -- FY earnings; signs agreement to acquire Nisbets in the UK and Pamark in Finland

        • -2.2% BARN.SW (Barry Callebaut CHF1,291.00, -29.00) -- Barry Callebaut to cut almost one in five jobs - Handelsblatt, citing interview with CEO Peter Feld

        • -2.0% ALFRE.FP (Freelance.com €3.43, -0.07) -- prelim FY revenue

        • -1.5% JLP.LN (Jubilee Metals Group £0.05, -0.00) -- H1 earnings

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: ASM International (ASM.NA), Cie d'Entreprises CFE (CFEB.BB)

        • DACHs: MunichRe (MUV2.GR), PUMA (PUM.GR), Durr (DUE.GR), flatexDEGIRO (FTK.GR), Adtran Networks (ADV.GR), New Work (NWO.GR), Straumann (STMN.SW), SIG Group (SIGN.SW), PSP Swiss Property (PSPN.SW), Arbonia (ARBN.SW), Bellevue (BBN.SW)

        • France: Bouygues (EN.FP), Edenred (EDEN.FP), Eurofins Scientific (ERF.FP), Lagarde (MMB.FP), Coface (COFA.FP)

        • Nordics: Jyske Bank (JYSK.DC), Zealand Pharma (ZEAL.DC), Per Aarsleff (PAAL.B.DC), Millicom International Cellular (TIGO.SS), Siem Offshore (SIOFF.NO), MPC Container Ships (MPCC.NO), Måsøval (MAS.NO), Integrated Wind Solutions (IWS.NO)

        • Southern Europe: Ferrovial (FER.SM), Naturgy Energy (NTGY.SM), Laboratorios Farmaceuticos Rovi (ROVI.SM), Gestamp Automocion (GEST.SM), Construcciones y Auxiliar de Ferrocarriles (CAF.SM), Semapa (SEM.PL), IGD SIIQ (IGD.IM), Davide Campari-Milano (CPR.IM)

        • UK/Ireland: Smith & Nephew (SN.LN), Croda International (CRDA.LN), The UNITE Group (UTG.LN), abrdn (ABDN.LN), Kitwave Group lc (KITW.LN), McBride (MCB.LN), Uniphar (UPR.ID)

      • Trading Update: Adocia (ADOC.FP), Bilendi (ALBLD.FP)

      • CMD/events: Aperam (APAM.NA), International Public Partnerships (INPP.LN)

  • Data:

    • Economics:

      • Spain Jan PPI (3.8%) y/y vs consensus (5.0%) and prior (6.3%)

    • Markets:

      • WTI Crude (Apr 24): +$0.75 or +0.98% to $77.24

      • €-$ +0.0027 or +0.25% to 1.0850

      • £-$ +0.0000 or +0.00% to 1.2676

      • €-£ +0.0022 to 0.8561

      • S&P 500 (0.07%)

      • Performance year-to-date

        • FTSE 100: (0.63%)

        • DAX: +4.01%

        • CAC: +5.13%

        • MIB: +7.27%

        • Stoxx 600: +3.43%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE